Ramírez-Moya, Julia http://orcid.org/0000-0002-2458-2186
Miliotis, Christos
Baker, Allison R.
Gregory, Richard I.
Slack, Frank J.
Santisteban, Pilar http://orcid.org/0000-0002-2758-796X
Funding for this research was provided by:
Fondo europeo de desarrollo regional (SAF2016-75531-R)
Ministerio de Ciencia e Innovación (PID2019-105303RB-I00/AEI/10.13039/501100011033)
Comunidad de Madrid (B2017/BMD-3724)
Fundación española contra el cáncer (GCB14142311CRES)
National Institutes of Health (R35 CA232105)
national cancer institute (outstanding Investigator Award (R35CA232115))
Article History
Received: 4 March 2021
Accepted: 3 August 2021
First Online: 8 September 2021
Declarations
:
: Ethics approval and consent to participate was obtained from all the patients following the protocols approved by the hospital ethics committee (Hospital Universitario La Paz, Madrid, Spain).
: The patients involved in our study gave consent for publication to the Biobank of the Hospital.
: RI-G and FJ-S are co-founders and scientific advisory board members of 28–7 Therapeutics and Theon Therapeutics.